Bio-View Ltd (BIOV.TA)
ILA 29.4
(0.0%)
ILA 29.4
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.65 Million ILS | 7.31% |
| 2022 | 13.65 Million ILS | 6.18% |
| 2021 | 12.85 Million ILS | 45.77% |
| 2020 | 8.82 Million ILS | -26.7% |
| 2019 | 12.03 Million ILS | 12.88% |
| 2018 | 10.66 Million ILS | -5.3% |
| 2017 | 11.25 Million ILS | 1.39% |
| 2016 | 11.1 Million ILS | 6.85% |
| 2015 | 10.39 Million ILS | -19.72% |
| 2014 | 12.94 Million ILS | 6.16% |
| 2013 | 12.19 Million ILS | -7.14% |
| 2012 | 13.13 Million ILS | -8.26% |
| 2011 | 14.31 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 13.4 Million ILS | 0.0% |
| 2024 Q1 | 13.4 Million ILS | -8.5% |
| 2023 FY | 14.65 Million ILS | 7.31% |
| 2023 Q1 | 13.78 Million ILS | 0.97% |
| 2023 Q4 | 14.65 Million ILS | 0.0% |
| 2023 Q3 | 14.65 Million ILS | 6.27% |
| 2023 Q2 | 13.78 Million ILS | 0.0% |
| 2022 Q4 | 13.65 Million ILS | 8.47% |
| 2022 Q2 | 12.98 Million ILS | 6.43% |
| 2022 Q1 | 12.2 Million ILS | -5.08% |
| 2022 Q3 | 12.58 Million ILS | -3.1% |
| 2022 FY | 13.65 Million ILS | 6.18% |
| 2021 FY | 12.85 Million ILS | 45.77% |
| 2021 Q1 | 12.78 Million ILS | 44.98% |
| 2021 Q2 | 12.67 Million ILS | -0.86% |
| 2021 Q3 | 12.69 Million ILS | 0.11% |
| 2021 Q4 | 12.85 Million ILS | 1.31% |
| 2020 FY | 8.82 Million ILS | -26.7% |
| 2020 Q1 | 9.76 Million ILS | -18.86% |
| 2020 Q2 | 8.27 Million ILS | -15.24% |
| 2020 Q3 | 8.7 Million ILS | 5.22% |
| 2020 Q4 | 8.82 Million ILS | 1.29% |
| 2019 Q3 | 10.54 Million ILS | -13.77% |
| 2019 FY | 12.03 Million ILS | 12.88% |
| 2019 Q1 | 14.43 Million ILS | 35.41% |
| 2019 Q2 | 12.22 Million ILS | -15.31% |
| 2019 Q4 | 12.03 Million ILS | 14.14% |
| 2018 FY | 10.66 Million ILS | -5.3% |
| 2018 Q4 | 10.66 Million ILS | 0.0% |
| 2018 Q2 | 11.16 Million ILS | 0.0% |
| 2018 Q1 | - ILS | -100.0% |
| 2017 Q4 | 11.25 Million ILS | 13.8% |
| 2017 FY | 11.25 Million ILS | 1.39% |
| 2017 Q3 | 9.89 Million ILS | 1.07% |
| 2017 Q2 | 9.78 Million ILS | 17.24% |
| 2017 Q1 | 8.34 Million ILS | -24.81% |
| 2016 FY | 11.1 Million ILS | 6.85% |
| 2016 Q2 | 11.1 Million ILS | 2.21% |
| 2016 Q3 | 11.62 Million ILS | 4.66% |
| 2016 Q4 | 11.1 Million ILS | -4.5% |
| 2016 Q1 | 10.86 Million ILS | 4.59% |
| 2015 Q1 | 9.88 Million ILS | -23.62% |
| 2015 Q3 | 11.67 Million ILS | 29.11% |
| 2015 Q4 | 10.39 Million ILS | -10.99% |
| 2015 Q2 | 9.04 Million ILS | -8.54% |
| 2015 FY | 10.39 Million ILS | -19.72% |
| 2014 Q4 | 12.94 Million ILS | 48.1% |
| 2014 Q3 | 8.74 Million ILS | 9.41% |
| 2014 FY | 12.94 Million ILS | 6.16% |
| 2014 Q1 | 8.44 Million ILS | 6.27% |
| 2014 Q2 | 7.98 Million ILS | -5.4% |
| 2013 Q3 | 8.03 Million ILS | 16.47% |
| 2013 FY | 12.19 Million ILS | -7.14% |
| 2013 Q4 | 7.94 Million ILS | -1.1% |
| 2013 Q1 | 8.36 Million ILS | 0.0% |
| 2013 Q2 | 6.89 Million ILS | -17.51% |
| 2012 FY | 13.13 Million ILS | -8.26% |
| 2011 FY | 14.31 Million ILS | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|